Frederik F Strobl1, Beatrice Kuhlin2, Robert Stahl2, Bastian O Sabel2, Andreas D Helck2, Andreas Schindler2, Matthias Witt3, Fabian Bamberg2,4, Maximilian F Reiser2, Tobias Saam2. 1. Department of Radiology, Ludwig-Maximilians-University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. frederik.strobl@med.lmu.de. 2. Department of Radiology, Ludwig-Maximilians-University Hospital Munich, Marchioninistr. 15, 81377, Munich, Germany. 3. Internal Medicine IV, Division of Rheumatology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany. 4. Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany.
Abstract
BACKGROUND: Intracranial arterial calcifications (ICAC) are often detected on unenhanced CT of patients with an age > 60. However, association with the subsequent occurrence of major adverse cardiovascular events (MACE) has not yet been evaluated. PURPOSE: This study aimed at evaluating the association of ICAC with subsequent MACE and overall mortality. METHODS: In this retrospective, IRB approved study, we included 175 consecutive patients (89 males, mean age 78.3 ± 8.5 years) of age > 60 years who underwent an unenhanced CT of the head due to minor trauma or neurological disorders. Presence of ICAC was determined in seven intracranial arteries using a semi-quantitative scale, which resulted in the calcified plaque score (CPS). Clinical follow-up information was obtained by questionnaires and telephone interviews. MACE was defined as myocardial infarction or revascularization, stroke or death due to cardiovascular event. RESULTS: Mean follow-up time was 39.8 ± 7.8 months, resulting in 579.7 patient-years of follow-up. Overall, 36 MACE occurred during follow-up (annual event rate = 6.2%/year). Mean CPS was significantly higher in subjects with MACE during follow-up compared to subjects without MACE (p < 0.01). In 15 patients CPS was 0; in none of these patients MACE was registered. Kaplan-Meier-analysis revealed that patients with a low plaque burden (CPS < 5) had a significant longer MACE-free and overall survival than patients with a high plaque burden (CPS ≥ 5) (p < 0.01). CONCLUSION: Patients with ICAC have an increased risk for future cardio- or cerebrovascular events. Therefore, ICAC might be a prognostic factor to determine the risk for these events in older patients.
BACKGROUND:Intracranial arterial calcifications (ICAC) are often detected on unenhanced CT of patients with an age > 60. However, association with the subsequent occurrence of major adverse cardiovascular events (MACE) has not yet been evaluated. PURPOSE: This study aimed at evaluating the association of ICAC with subsequent MACE and overall mortality. METHODS: In this retrospective, IRB approved study, we included 175 consecutive patients (89 males, mean age 78.3 ± 8.5 years) of age > 60 years who underwent an unenhanced CT of the head due to minor trauma or neurological disorders. Presence of ICAC was determined in seven intracranial arteries using a semi-quantitative scale, which resulted in the calcified plaque score (CPS). Clinical follow-up information was obtained by questionnaires and telephone interviews. MACE was defined as myocardial infarction or revascularization, stroke or death due to cardiovascular event. RESULTS: Mean follow-up time was 39.8 ± 7.8 months, resulting in 579.7 patient-years of follow-up. Overall, 36 MACE occurred during follow-up (annual event rate = 6.2%/year). Mean CPS was significantly higher in subjects with MACE during follow-up compared to subjects without MACE (p < 0.01). In 15 patientsCPS was 0; in none of these patients MACE was registered. Kaplan-Meier-analysis revealed that patients with a low plaque burden (CPS < 5) had a significant longer MACE-free and overall survival than patients with a high plaque burden (CPS ≥ 5) (p < 0.01). CONCLUSION:Patients with ICAC have an increased risk for future cardio- or cerebrovascular events. Therefore, ICAC might be a prognostic factor to determine the risk for these events in older patients.
Authors: Florian Schwarz; Frederik F Strobl; Clemens C Cyran; Andreas D Helck; Martin Hartmann; Andreas Schindler; Konstantin Nikolaou; Maximilian F Reiser; Tobias Saam Journal: Neuroradiology Date: 2016-02-23 Impact factor: 2.804
Authors: María Hernández-Pérez; Daniel Bos; Laura Dorado; Karlijn Pellikaan; Meike W Vernooij; Elena López-Cancio; Natalia Pérez de la Ossa; Meritxell Gomis; Carlos Castaño; Josep Munuera; Josep Puig; Mònica Millán; Antoni Dávalos Journal: Stroke Date: 2016-12-22 Impact factor: 7.914
Authors: Allen J Taylor; Jody Bindeman; Irwin Feuerstein; Felix Cao; Michael Brazaitis; Patrick G O'Malley Journal: J Am Coll Cardiol Date: 2005-09-06 Impact factor: 24.094
Authors: S Koton; V Tashlykov; Y Schwammenthal; N Molshatzki; O Merzeliak; R Tsabari; D Tanne Journal: Eur J Neurol Date: 2011-12-19 Impact factor: 6.089
Authors: G Sangiorgi; J A Rumberger; A Severson; W D Edwards; J Gregoire; L A Fitzpatrick; R S Schwartz Journal: J Am Coll Cardiol Date: 1998-01 Impact factor: 24.094
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis Journal: Circulation Date: 1995-05-01 Impact factor: 29.690